Surgery of basal cell carcinoma around the lacrimal canaliculus can be necessary after primary treatment with intralesional interferon alpha 2b

Huerva, V.; Mangues, I.
January 2008
Indian Journal of Ophthalmology;Jan2008, Vol. 56 Issue 1, p85
Academic Journal
No abstract available.


Related Articles

  • Bazal hücreli karsinomda tek başına veya intralezyonel interferon ile birlikte imikimod kullanımı ile klinik baÅŸarı. Sarıcaoğlu, Hayriye; Algan, Sema İpek; Turan, Ayşegül; Başkan, Emel Bülbül; Turan, Hakan; Adım, Şaduman Balaban // Archives of the Turkish Dermatology & Venerology / Turkderm;Oct2013, Vol. 47 Issue 4, p239 

    Basal cell carcinoma (BCC) is the most common type of skin cancer in humans. Surgery is still the gold standard for treating BCCs. However, there are also less-invasive, nonsurgical therapies such as imiquimod cream and intralesional interferon (IFN) alpha-2b for patients who are poor surgical...

  • Treatment of basal cell carcinoma with intralesional interferon alpha-2b. Healsnilth, M. F.; Berth-Jones, J.; Fletcher, A.; Graham-Brown, R. A. C. // Journal of the Royal Society of Medicine;Sep1991, Vol. 84 Issue 9, p524 

    We report a series of 11 basal cell carcinomas of various types treated with nine intralesional injections of 1.5 million units of interferon alpha-2b. The diagnosis was confirmed histologically in each case. After 3 months' follow-up six tumours had resolved both clinically and histologically....

  • Review of the Literature.  // Journal of Dermatologic Surgery & Oncology;May93, Vol. 19 Issue 5, p501 

    The article analyzes several literatures presenting case studies based on skin surgery and oncology, published in various medical journals. "Treatment of Cutaneous Squamous Cell Carcinomas by Intralesional Interferon Alpha-2b Therapy," by L. Edwards, B. Berman, R.P. Rapini and others, focuses on...

  • Intralesional chemotherapy. GUTTMAN, CHERYL // Dermatology Times;Feb2009, Vol. 30 Issue 2, p72 

    The article discusses a study which reviews the efficacy and safety of intralesional chemotherapy for nonmelanoma skin cancer. The study was based on studies which investigated the treatment of cutaneous basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or keratoacanthoma (KA) using...

  • Interferon-α-2b.  // Reactions Weekly;May2014, Vol. 1501 Issue 1, p26 

    An abstract of the article "Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face," by A. Hanlon and colleagues is presented.

  • Management of lacrimal sac tumours. Parmar, D N; Rose, G E // Eye;Jul2003, Vol. 17 Issue 5, p599 

    Purpose To report a series of 15 primary lacrimal sac tumours and present an algorithm in managing this rare condition. Design Noncomparative interventional case series. Methods A retrospective review of the clinical, radiological, and pathological records of 15 patients with primary lacrimal...

  • Blue light option: Alternative to surgery for basal cell carcinoma has ups, downs. Schwanke, Jane // Dermatology Times;May2011, Vol. 32 Issue 5, p48 

    The article presents results of the study on the effectiveness of noncoherent blue light in the intralesional photodynamic therapy (PDT) in treating basal cell carcinoma (BCC). It says that the method can be used as an alternative surgery in treating BCC. According to Roy G. Geronemus, one of...

  • Basal Cell Carcinoma--New Aspects of Diagnosis and Treatment. Wennberg, Ann-Marie // Acta Dermato-Venereologica;May2000 Supplement 209, Vol. 80, p5 

    Focuses on the aspects of diagnosis and treatment for basal cell carcinoma (BCC). Use of interferon for treatment of BCC; Critical factor in using ALA; Recommendation of Mohs Micrographic Surgery for BCC with ill-defined borders.

  • Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon α-2a: Evaluation of Long-Term Follow-Up Results. Bostanci, Seher; Kocyigit, Pelin; Alp, Ayşegül; Erdem, Cengizhan; Gürgey, Erbak // Clinical Drug Investigation;2005, Vol. 25 Issue 10, p661 

    Objective: Intralesional injections of interferon have been reported to provide successful results in the treatment of basal cell carcinoma. However, there are only a few reports describing the long-term efficacy of this therapy. The aim of our study was to evaluate the efficacy and long-term...

  • Mohs Surgery for Periocular Basal Cell Carcinomas. Robins, Perry; Rodríguez-Sains, René; Rabinovitz, Harold; Rigel, Darrell // Journal of Dermatologic Surgery & Oncology;Dec85, Vol. 11 Issue 12, p1203 

    Cure rates for 631 periocular basal cell carcinomas treated by Mohs surgery proved to be 98.1% for primary lesions and 93.6% for previously treated lesions. All recurrences of primary lesions post-Mobs surgery were located in the medial canthus. Among lesions previously treated, recurrence rates...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics